Jump to navigation
The medical schools in Tucson and Phoenix are engaged in several efforts related to recruitment, retention, mentoring, faculty development, curriculum, culture and more.
A. Elizabeth "Betsy" Arnold, Carol Gregorio and Cecile McKee are the newest fellows of the American Association for the Advancement of Science.
University of Arizona researchers suggest the risk of developing dementia after a stroke might be reduced by a drug that could help immune cells process the cholesterol-rich debris generated by a stroke.
Jennifer Barton has spent nearly a decade developing a falloposcope to detect ovarian cancer in its early stages. Dr. John Heusinkveld has now successfully used the device to capture images of study participants' fallopian tubes.
The NIH RECOVER Initiative aims to identify risks contributing to long COVID, and approaches for treatment and prevention.
Researchers from the UArizona College of Medicine – Tucson found that the bacterial lysate OM-85 blocked SARS-CoV-2 infection by decreasing the ability of the coronavirus to bind to the lung cell surface receptor ACE2.
A University of Arizona Health Sciences-led research team received $7.16 million in federal funding to study how to better control severe asthma and determine why sufferers are less likely to contract COVID-19, influenza and rhinovirus.
For their technological contributions to engineering and health care, Liesl Folks, Mark Van Dyke and Terry Matsunaga have been recognized with the highest professional distinction for academic inventors.
Two grants totaling more than $1.3 million will help establish the Native Center for Disabilities, which aims to bring tribal communities together to improve services and employment access for Native Americans with disabilities.
Researchers targeted a common sodium ion channel to reverse pain and saw positive results that could lead to a nonaddictive solution to treat pain.